Information & documents for professionals
Does your center want to participate? Join us! Please see the infographic below on which steps you have to take. Click here to view the infographic intended for Dutch hospitals only.
A pneumonia of unknown cause occurring in Wuhan, China was reported on 31 December 2019 to the WHO Country Office in China. A new coronavirus virus called SARS-CoV-2 turned out to be the cause of the outbreak. This virus can cause the disease COVID-19. Due to rapid spreading of the virus, the WHO declared the outbreak a Public Health Emergency of International Concern on 30 January 2020. Since 11 March 2020, COVID-19 is considered to be a pandemic.
From emerging literature on the clinical disease manifestation of COVID-19, fever and respiratory symptoms seem most common. However, a significant number of patients develops cardiovascular complications. Furthermore, patients with pre-existent cardiovascular comorbidities seem to have an increased chance of developing serious complications of COVID-19. Insufficient evidence is currently available to guide monitoring of cardiovascular complications and treatment decisions in COVID-19 patients with a history of cardiovascular disease.
CAPACITY is a registry of patients with COVID-19 including cardiovascular risk and complications. It is an extension of the Case Record Form (CRF) that was released by the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) and WHO (World Health Organisation) in response to the emerging outbreak of COVID-19.
The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the establishment and incidence of cardiovascular complications in patients with COVID-19, and (2) the vulnerability and clinical course of COVID-19 in patients with an underlying cardiovascular disease.
Please contact us for the Data Transfer Agreement (DTA).
Together we are investigating the role cardiovascular disease in the COVID-19 pandemic. We sincerely invite our international colleagues and researchers to apply for data access or to join efforts that are already ongoing. The following six research questions have formulated by the Data Access Committee and are being assessed:
Contact us to join already ongoing projects
How to apply for data access:
All patients who have tested positive or are highly suspected of COVID-19 and are admitted to the hospital. Patients who do not opt-out can be included in the registry.
This research is observational, data acquired during routine clinical care will be registered. Data of the admission will be collected with standardized Data Collection Instruments in REDCap. In addition to the ISARIC-WHO CRF, the CAPACITY REDCap project has multiple additional Data Collection Instruments, including: cardiac history and cardiovascular risk factors, cardiac biomarkers, ECG, echocardiography, cardiac MRI, invasive cardiac procedures, cardiac complications during admission and cardiac outcome after 7 and 30 days.
Data will be stored secured and de-identified by using a unique study code in a REDCap registry.